Thyroid cancer: Evidence-based optimal management and the search for a cure

Clinical Oncology

Volumn 22, Issue 6, 2010, Pages 394-

  Mallick, U K ^a  

^a FREEMAN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA DIRECTED DNA POLYMERASE BETA; THYROTROPIN;

CANCER MODEL; CANCER SUSCEPTIBILITY; CELL FUNCTION; DIAGNOSTIC PROCEDURE; EDITORIAL; EVIDENCE BASED PRACTICE; MOLECULARLY TARGETED THERAPY; PRIORITY JOURNAL; PROTEOMICS; THYROID CANCER; DISEASE MANAGEMENT; EVIDENCE BASED MEDICINE; HUMAN; PRACTICE GUIDELINE; THYROID NEOPLASMS; TRANSLATIONAL RESEARCH;

DISEASE MANAGEMENT; EVIDENCE-BASED MEDICINE; HUMANS; PRACTICE GUIDELINES AS TOPIC; THYROID NEOPLASMS; TRANSLATIONAL RESEARCH; TRANSLATIONAL MEDICAL RESEARCH;

EID: 77954761648     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2010.05.019     Document Type: Editorial

References (8)

1. Eliot T.S. Choruses from " The Rock" 1934. Selected poems 1961, Faber and Faber London.
2. Cooper D.S., Doherty G.M., Haughen B.R., et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009, 19(11):1167-1214.
3. Cheng S.Y., Ringel M.D. Frontiers in thyroid cancer. Thyroid 2009, 19(12):1297-1298.
4. Nikiforova M.N., Nikiforov Y.E. Molecular diagnostics and predictors in thyroid cancer. Thyroid 2009, 19(12):1351-1361.
5. Damante G., Scaloni A., Tell G. Thyroid tumors: novel insights from proteomic studies. Expert Rev Proteomics 2009, 6(4):363-376.
6. Baril P., Martin-Duque P., Vassaux G. Visualization of gene expression in the live subject using the Na/I symporter as a reporter gene: applications in biotherapy. Br J Pharmacol 2009, 159(4):761-771.
7. Hingorani M., Spitzweg C., Vassaux G., et al. The biology of the sodium iodide symporter and its potential for targeted gene delivery. Curr Cancer Drug Targets 2010, 10(2):242-267.
8. Li W., Ain K. Human sodium/iodide symporter (hNIS) gene expression is inhibited by a trans-active transcriptional repressor, NIS-repressor, containing PARP-1 in thyroid cancer cells. Endocr Relat Cancer 2010, 17(2):383-398.